FPM/ABHI Webinar: Companion Diagnostics: Pathways, Policy and Practice

Explore the evolving UK companion diagnostics landscape.

Companion diagnostics (CDx) are tests, often in vitro diagnostics, used to help identify which patients are most likely to benefit from a specific medicine, enabling more targeted and effective treatment decisions. As a key part of the HealthTech ecosystem, CDx sit at the intersection of medical devices, diagnostics, medicines and data, and are increasingly critical to delivering precision medicine in practice.

In partnership with the Association of British HealthTech Industries (ABHI), we’re bringing you a new webinar exploring the evolving CDx landscape in the UK. The session will focus on the practical pathways that support adoption, the policy environment shaping patient access, and the opportunities to strengthen collaboration across the diagnostics and medicines ecosystem.

This session will cover:

• How companion diagnostics are being used in clinical practice and where future potential lies.
• Evidence generation, evaluation and adoption pathways, and what can delay access.
• Key policy considerations, including regulation and commissioning.
• How industry, clinicians and policymakers can support more joined-up decision-making to accelerate impact for patients and the NHS.

This webinar offers a valuable opportunity to hear expert perspectives and engage in discussion on what’s needed to make companion diagnostics work effectively for patients and the NHS.